drugset / Trial / NCT00564772
Raltegravir Kaletra Pharmacokinetics
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This will be an open-label, 3-period, fixed sequence study in young, healthy, male and female subjects of the pharmacokinetic interaction between raltegravir and Kaletra.
Timeline
- Start
- 2007-11
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lopinavir | Other / unclassified | — | — |
| Subject | Raltegravir | Other / unclassified | 400 mg | — |
| Subject | Ritonavir | Other / unclassified | — | — |
Indications
No indication recorded.